| Danone: Continued Strong Momentum In Q3 Consistently Delivering Quality Growth |
| § Sales reached €6,826m in Q3 2024, up +4.2% on a like-for-like (LFL) basis |
| § Strong volume/mix, up +3.6%, and price up +0.7%; volume/mix and price positive in all categories |
| § Continued strong performance in North America driven by High Protein, Coffee Creations and Waters |
| § Further acceleration in Europe volume/mix, driven by EDP |
| § Another quarter of strong competitive momentum in China, North Asia & Oceania, led by all categories |
| § 2024 guidance confirmed: like-for-like sales growth expected between +3% and +5%, with moderate improvement in recurring operating margin |
|
€ million except % |
Q3 2023 |
Q3 2024 |
Reported change |
LFL sales growth |
Volume/ mix growth |
9M
2023 |
9M
2024 |
Reported change |
LFL sales growth |
Volume/ mix growth |
| BY GEOGRAPHICAL ZONE |
| Europe |
2,392 |
2,427 |
+1.5% |
+1.4% |
+2.4% |
7,069 |
7,210 |
+2.0% |
+1.6% |
+0.9% |
| North America |
1,747 |
1,611 |
-7.7% |
+5.8% |
+4.9% |
5,164 |
4,943 |
-4.3% |
+4.4% |
+3.5% |
| China, North Asia & Oceania |
896 |
967 |
+7.9% |
+8.0% |
+10.2% |
2,674 |
2,808 |
+5.0% |
+8.4% |
+8.9% |
| Latin America |
771 |
706 |
-8.5% |
+2.7% |
-0.7% |
2,233 |
2,265 |
+1.4% |
+4.0% |
-0.4% |
| Rest of the World |
1,100 |
1,115 |
+1.4% |
+6.0% |
+1.2% |
3,977 |
3,350 |
-15.8% |
+5.8% |
+1.4% |
| BY CATEGORY |
| EDP |
3,474 |
3,283 |
-5.5% |
+4.1% |
+3.8% |
10,973 |
10,066 |
-8.3% |
+3.5% |
+2.4% |
| Specialized Nutrition |
2,070 |
2,189 |
+5.7% |
+5.2% |
+4.1% |
6,369 |
6,599 |
+3.6% |
+4.6% |
+2.7% |
| Waters |
1,362 |
1,354 |
-0.6% |
+3.2% |
+2.3% |
3,775 |
3,910 |
+3.6% |
+5.0% |
+2.9% |
| |
| TOTAL |
6,906 |
6,826 |
-1.2% |
+4.2% |
+3.6% |
21,118 |
20,575 |
-2.6% |
+4.1% |
+2.6% |
|
| Antoine de Saint-Affrique: CEO statement |
| With like-for-like sales growth of +4.2% in Q3, driven by +3.6% volume/mix, we continue to deliver broad-based quality growth, with both volume/mix and price positive in all categories. |
| Our consistent focus on science-based and consumer and patient-centric innovation, combined with strong in-market execution keeps paying off, as demonstrated by the continued good performance of our winning platforms such as High Protein, Coffee Creations and Medical Nutrition. We have also improved competitiveness within our Core portfolio across many geographies. |
| In what remains a challenging environment, we view our future with confidence, further leveraging the fundamentals we reestablished with Renew Danone. |
| For the full document click the link below: |
| Danone |
| Stay ahead of the curve! Subscribe to InsidEntity for daily updates on all your favourite companies. |
